Skip to main content
SpringerLink
Log in

The Strategic Impact of Internet Technology in Biotechnology and Pharmaceutical Firms: Insights from a Knowledge Management Perspective

  • Published:
Information Technology and Management Aims and scope Submit manuscript

Abstract

This paper conceptualises the strategic impact of new Internet technology in biotechnology and pharmaceutical firms. It argues that competitiveness of modern, agile pharmaceutical businesses depend on their ability to create and commercialise new knowledge as much as on their ability to produce new products. Hence, knowledge production and intellectual property management provide a strong foundation for emerging, successful e-commerce strategies. The authors suggest Knowledge Management (KM) plays a key role in determining organizational performance levels and value creation. KM refers to technologies for processing information and generating and distributing knowledge, but also to organizational structures (such as virtual enterprise designs) that increase strategic fit and effectiveness of KM implementations. The Internet is seen as core technology enabling the creation of organizational networks (virtual teams; virtual customer-supplier communities). More specifically, this paper devises a new classificatory framework that categorises the strategic impact of Internet technology in the biotechnology and pharmaceutical industry, which is based on three key dimensions: converting information into knowledge, the redesign of the innovation process, and knowledge-oriented organisational structuring. The authors extend their framework beyond the boundaries of the firm to include relationship with customers, suppliers, intermediaries such as specialist biotech companies and healthcare professionals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S. Albertini and J. Butler, R & D networking in a pharmaceutical company: Some implications for human resource management, R & D Management 25 (1995) 377–393.

    Google Scholar 

  2. R. Andreu and C. Ciborra, Organisational learning and core capabilities development: The role of IT, Journal of Strategic Information Systems 5 (1996) 111–127.

    Google Scholar 

  3. T. Bertels and C. Savage, Tough questions on knowledge managementn, in: Knowing in Firms: Understanding, Managing and Measuring Knowledge, eds. G. von Krogh et al. (Sage Publications, 1998).

  4. F. Blacker, Knowledge, knowledge work and organisations, an overview and interpretation, Organisation Studies 16 (1995) 1021–1046.

    Google Scholar 

  5. F. Blacker, N. Crump and S. McDonald, Knowledge, organizations and competition, in: Knowing in Firms: Understanding, Managing and Measuring Knowledge, eds. G. von Krogh et al. (Sage Publications, 1998).

  6. E. Bolisani, E. Scarso, I. Miles and M. Boden, Electronic commerce implementation: Knowledgebased analysis, International Journal of Electronic Commerce 3(3) (1999) 53–69.

    Google Scholar 

  7. J. Burn and C. Ash, Managing knowledge for strategic advantage in the virtual organization, in: Knowledge Management and Virtual Organizations, ed. Y. Malhotra (Idea Group Publishing, 2000).

  8. K. Capell, H. Dawley and A. Barret, Strong medicine: The Glaxo SmithKline merger may prompt other big deals, Business Week (31 January 2000) 18–19.

  9. B.N. Cavan, Improving clinical trials cost management in biotech companies, Biotechnology 13 (1995) 226–228.

    Google Scholar 

  10. H. Chesbrough and D.J. Teece, When is virtual virtuous?, Harvard Business Review (January/ February 1996) 65–73.

  11. V. Chiesa and R. Manzini, Managing virtual R & D organizations: Lessons from the pharmaceutical industry, International Journal of Technology Management 13 (1997) 471–485.

    Google Scholar 

  12. F. Della Valle and A. Gambardella, Biological revolution and strategies for innovation in pharmaceutical companies, R & D Management 23(4) (1993).

  13. O. El Sawy, A. Malhorta, S. Gosain and K.M. Young, IT-intensive value innovation in the electronic economy: Insights from Marshall industries, MIS Quarterly 23(3) (1999) 305–333.

    Google Scholar 

  14. European Commission, Accelerating Electronic Commerce in Europe (Commission of the European Communities, Luxembourg, 1998). http://www.ispo.cec.be/ecommerce/ecbook.htm.

    Google Scholar 

  15. A. Gambardella, Science and Innovation: The US Pharmaceutical Industry During the 1980s (Cambridge University Press, Cambridge, 1995).

    Google Scholar 

  16. M. Hansen, N. Nohria and T. Tierney, What's your strategy for managing knowledge?, Harvard Business Review (March/April 1999) 106–119.

  17. J. Howells, Going global: The use of ICT networks in research and development, Research Policy 24 (1995) 169–184.

    Google Scholar 

  18. J. Howells and M. Wood, The diffusion and management of EDI: Barriers and opportunities in the UK pharmaceutical and healthcare industries, Technology Analysis and Strategic Management 7 (1993) 371–386.

    Google Scholar 

  19. K. Ichijo, G. von Krogh and I. Nonaka, Knowledge enablers, in: Knowing in Firms: Understanding, Managing and Measuring Knowledge, eds. G. von Krogh et al. (Sage Publications, 1998).

  20. R. James, Sense, scale and scope in pharmaceutical R & D, in: Proceedings of the ‘Knowledge Management: Concepts and Controversies’ Conference, University of Warwick, Kenilworth, 10–11 February 2000, pp. 47–48.

    Google Scholar 

  21. R. Kalakota and M. Robinson, e-Business: Roadmap for Success (Wiley, Chichester, 1999).

    Google Scholar 

  22. M. Kenney and J. Curry, E-commerce: Implications for firm strategy and industry configuration, Industry and Innovation 6 (1999) 131–151.

    Google Scholar 

  23. J. Lipnack and J. Stamps, Virtual teams: The new way to work, Engineering Management Review 27(4) (1999) 90–95.

    Google Scholar 

  24. Y. Malhotra, Knowledge management and new organization forms: A framework for business model innovation, in: Knowledge Management and Virtual Organizations, ed. Y. Malhotra (Idea Group Publishing, 2000).

  25. T.W. Malone, J. Yates and R.I. Benjamin, Electronic markets and electronic hierarchies, Communications of the ACM 30 (1997) 484–497.

    Google Scholar 

  26. D. Marchand, Competing with Intellectual Capital, in: Knowing in Firms: Understanding, Managing and Measuring Knowledge, eds. G. von Krogh et al. (Sage Publications, 1998).

  27. D.A. Nadler and M.L. Tushman, The organization of the future: Strategic imperatives and core competencies for the 21st Century, Engineering Management Review 27(4) (1997) 96–107.

    Google Scholar 

  28. NHSE, Clinical Governance: Quality in the New NHS (National Health Service Executive, Leeds, 1999).

    Google Scholar 

  29. S.L. Oswald and W.R. Boulton, Obtaining industry control: The case of pharmaceutical distribution industry, California Management Review 38(1) (1995) 138–162.

    Google Scholar 

  30. Pharmaceutical Industry Competitiveness Task Force, Clinical Research Report, Department of Health, London (2001).

  31. G.P. Pisano, The R & D boundaries of the firm: An empirical analysis, Administrative Science Quarterly 35 (1990) 153–176.

    Google Scholar 

  32. G.P. Pisano, Knowledge, integration and the locus of learning: An empirical analysis of process development, Strategic Management Journal 15 (1994) 85–100.

    Google Scholar 

  33. G. Pisano and S. Wheelwright, High-Tech R & D, Harvard Business Review (September/October 1995) 93–105.

  34. G.P. Pisano, W. Shaw and D.J. Teece, Joint ventures and collaboration in the biotechnology industry, in: International Collaborative Ventures in US Manufacturing, ed. D.C. Mowery (Ballinger, Cambridge, MA, 1998) pp. 182–222.

    Google Scholar 

  35. C. Prahalad and G. Hamel, The core competence of the corporation, Harvard Business Review 68 (1990) 79–91.

    Google Scholar 

  36. K. Randle and A. Rainnie, Creativity and control in a pharmaceutical R & D company: The case of Glaxo research and development, Working Paper Series No. 7, University of Hertfordshire Business School (1994).

  37. D. Schwartz, M. Divitini and T. Brasethvik, On knowledge management in the Internet age, in: Internet-Based Organizational Memory and Knowledge Management, eds. Schawartz et al. (Idea Group Publishing, 2000).

  38. J.A. Senn, Expanding the reach of electronic commerce: The Internet EDI alternative, Information Systems Management 15(3) (1998) 7–15.

    Google Scholar 

  39. C. Staropoli, Cooperation in R & D in the pharmaceutical industry: The network as an organizational innovation governing technological innovation, Technovation 18(1) (1998) 13–23.

    Google Scholar 

  40. P. Timmers, Electronic Commerce: Strategies and Models for Business-to-Business Trading, Wiley Series in Information Systems (Wiley, Chichester, 1999).

    Google Scholar 

  41. P. Verdin and P. Williamson, Core competencies, competitive advantage and market analysis: Forging the links, in: Competence-Based Competition, eds. G. Hamel and A. Heene (Wiley, Chichester, 1999).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Business School, Manchester Metropolitan University, Manchester, M13GH, UK

    Angel Salazar & Ray Hackney

  2. Policy Research in Engineering, Science and Technology, University of Manchester, Manchester, M13 9PL, UK

    Jeremy Howells

Authors
  1. Angel Salazar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ray Hackney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeremy Howells
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salazar, A., Hackney, R. & Howells, J. The Strategic Impact of Internet Technology in Biotechnology and Pharmaceutical Firms: Insights from a Knowledge Management Perspective. Information Technology and Management 4, 289–301 (2003). https://doi.org/10.1023/A:1022910614411

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022910614411

Search

Navigation